Longwood Construction Notice: Ongoing construction near our Longwood campus may affect traffic in the area. Check the latest access changes before you travel. If you are a journalist and have a ...
Longwood Construction Notice: Ongoing construction near our Longwood campus may affect traffic in the area. Check the latest access changes before you travel. If you are a journalist and have a ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide — a next-generation neoadjuvant androgen-receptor pathway ...
If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu. The Media Team cannot respond to ...
If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.
Prospective national study validates circulating tumor DNA as a predictor of relapse risk and identifies low-, intermediate-, and high-risk patient groups A blood test may help doctors identify which ...
Edward Chouchani, PhD, principal investigator of the Chouchani Lab at Dana-Farber Cancer Institute, was one of 18 scientists named as finalists for the 2026 Blavatnik National Awards for Young ...
A new study led by researchers at Dana-Farber Cancer Institute found that first-line trastuzumab deruxtecan (T-DXd) significantly improved progression-free survival compared with pembrolizumab plus ...
Mario Germano Giuliani and Lisa Giuliani have made an extraordinary gift of $27.8 million to support research in multiple myeloma, Dana-Farber Cancer Institute announced today. It is one of the ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
Richard K. and Nancy K. Lubin have made a $35 million gift to Dana-Farber Cancer Institute’s Future of Cancer Care Fund, which provides resources to the areas of greatest need at Dana-Farber, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results